Correlation Between Ascendis Pharma and Homology Medicines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and Homology Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and Homology Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascendis Pharma AS and Homology Medicines, you can compare the effects of market volatilities on Ascendis Pharma and Homology Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of Homology Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and Homology Medicines.

Diversification Opportunities for Ascendis Pharma and Homology Medicines

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Ascendis and Homology is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and Homology Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Homology Medicines and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with Homology Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Homology Medicines has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and Homology Medicines go up and down completely randomly.

Pair Corralation between Ascendis Pharma and Homology Medicines

If you would invest  12,944  in Ascendis Pharma AS on August 28, 2024 and sell it today you would earn a total of  141.00  from holding Ascendis Pharma AS or generate 1.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy4.76%
ValuesDaily Returns

Ascendis Pharma AS  vs.  Homology Medicines

 Performance 
       Timeline  
Ascendis Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ascendis Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Ascendis Pharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Homology Medicines 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Homology Medicines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Homology Medicines is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Ascendis Pharma and Homology Medicines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ascendis Pharma and Homology Medicines

The main advantage of trading using opposite Ascendis Pharma and Homology Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, Homology Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Homology Medicines will offset losses from the drop in Homology Medicines' long position.
The idea behind Ascendis Pharma AS and Homology Medicines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Directory
Find actively traded commodities issued by global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years